Blackstone has completed fundraising for its fourth institutional European direct lending fund, assembling approximately €13bn in investable capital across its latest fund and associated credit vehicles.
The final close of Blackstone European Senior Direct Lending Fund IV, known as BXDE IV, provides additional financing capacity for loans to European companies, particularly those in the middle and upper-middle market.
Blackstone said the approximately €13bn figure covers BXDE IV and other European direct lending vehicles established since the fund’s launch, including anticipated leverage.
It therefore represents the broader investable capital assembled through these arrangements, rather than the amount of equity commitments secured by the standalone institutional fund.
The distinction is important when assessing the scale of private credit fundraising. Lending vehicles can increase their investment capacity through financing arrangements that supplement capital committed by institutional investors, although leverage also introduces additional financial obligations.
BXDE IV will target European corporate borrowers across different sectors, with a particular focus on companies seeking substantial privately arranged debt financing.
Direct lending allows investment managers to negotiate loans directly with businesses, often financing acquisitions, refinancing existing debt, or supporting investment and expansion.
Unlike publicly syndicated borrowing, these transactions are generally arranged between a smaller group of lenders and borrowers. Financing terms can be negotiated around a company’s capital structure, cash flow, and transaction requirements.
The expansion of institutional direct lending has increased the range of financing options available to companies that previously relied heavily on banks and syndicated loan markets for substantial borrowing.
Private credit remains subject to conventional lending risks, including changes in borrower profitability, repayment difficulties, and the availability of refinancing when existing debt matures.
Blackstone has committed capital to several large European transactions during the fundraising period, illustrating the scale of financing undertaken through its wider credit platform.
These include a €1bn financing associated with Angelini Pharma’s proposed take-private of Catalyst Pharmaceuticals, as well as transactions involving Regnology, Odevo, and JTC.
Blackstone identified financing commitments of €780m for Regnology, €649m for Odevo, and €382m for JTC. The manager acted as a lead lender in these transactions.
Brad Marshall, global head of private credit strategies at Blackstone Credit & Insurance, said: “This fundraise reflects investors’ confidence in private credit and our ability to deliver scaled financing across market cycles.”
The latest fund builds on more than two decades of Blackstone credit investment in Europe. Its activities span corporate direct lending, infrastructure and asset-backed finance, and collateralised loan obligations.
Blackstone Credit & Insurance employs more than 100 investment professionals across five European offices in London, Dublin, Frankfurt, Milan, and Paris.
The European operation sits within a wider credit business serving institutional investors and borrowers through different types of privately negotiated and publicly traded debt.
Mike Carruthers, European head of private credit strategies at Blackstone Credit & Insurance, said the group continued to see European borrowers seeking certainty, financing scale, and flexibility in their funding arrangements.
The attraction of direct lending for borrowers depends partly on the terms available from competing financing providers. Interest costs, repayment schedules, security arrangements, and contractual restrictions all influence the suitability of privately arranged debt.
For investors, the return from these arrangements depends on the performance of underlying borrowers and the terms negotiated when loans are originated. The availability of substantial committed capital does not guarantee that it will all be deployed or produce the anticipated returns.
The new fundraising also forms part of Blackstone’s broader European investment strategy. The group has identified credit as an important component of its ambition to invest more than $500bn in European assets by 2035.
BXDE IV provides an additional pool of capital for that strategy, with future lending dependent on transaction opportunities, credit assessment, and investment decisions across Blackstone’s European operations.
You must be logged in to post a comment.